Daily Dispatch
The 'Dispatched' Podcast
BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.
Be sure to visit the podcast's website and support the creator: bpd.captivate.fm
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
The 'Dispatched' Week in Review Podcast - 29 August 29.08.2025 49:39
Patients should never accept a decision-making framework that requires them to sacrifice themselves for a mythical collective good, which is just the government getting the best deal for itself. More evidence of why we need to know what discussants present to HTA committees, and how they reflect personal opinions and ideologies. Financial results that confirm pharmacy's increasing role as a h...
The 'Dispatched' Week in Review Podcast - 22 August 22.08.2025 32:40
The minister focused on NDIS reform at this week's National Press Club address, suggesting that it is taking up a lot of his time. Implementing the HTA Review will be one side of a two-sided coin. While it might frustrate some, it represents a unique opportunity to secure positive outcomes from an inevitable negotiation.
The 'Dispatched' Week in Review Podcast - 15 August 15.08.2025 35:53
An update on the Government's travel policy! The opportunity of AI, our own journeys, and why it needs to be embraced and not feared, particularly in healthcare. Productivity and the impact of chronic conditions and another example of why it would be better to target support to those most in need.
The 'Dispatched' Week in Review Podcast - 8 August 08.08.2025 35:25
Government travel policies make us laugh and laugh. Understanding reforms from the government's perspective is critical to understand how they will evolve over time, and an update that raises more questions than it answers.
The 'Dispatched' Podcast 03.08.2025 22:37
A special episode focused on the AbbVie-commissioned survey, revealing firm support for increased investment in medicines and the true extent of patients paying the cost of their prescriptions. What does it mean and what is the opportunity?
The 'Dispatched' Week in Review Podcast - 1 August 01.08.2025 42:17
Another order on pharmaceutical pricing, but what does it mean? What does the Government's productivity roundtable have in common with the HTA Review? Screening programs that aren't, and a co-payment reduction that puts the safety net further out of reach.
The Dispatched 'Week in Review' Podcast - 27 July 27.07.2025 31:25
A sense of entitlement that needs to be questioned, Australia is on the list of nine countries to be targeted over pharmaceutical pricing, and the hopeless hypocrisy of allowing a group of disreputable regimes to have a say on this country's response to a pandemic, while fulminating about the US on the PBS.
The 'Dispatched' Week in Review Podcast - 17 July 17.07.2025 50:02
The opportunity for Australia is to do less deflecting on healthcare affordability and engage in an honest discussion about the genuine challenges confronting many Australians. The debate does not just deflect on affordability.
The 'Dispatched' Week in Review Podcast - 10 July 10.07.2025 37:11
The ongoing debate regarding the US, the Trump administration's potential tariffs on pharmaceuticals and the PBS is mainly characterised by falsehoods and errors. We discuss our incredible frustration over a debate that is almost entirely disconnected from facts, including the apparent belief that Australia has a vast array of advanced pharmaceutical manufacturing facilities. We also have pra...
The Dispatched 'Week in Review' Podcast - 4 July 04.07.2025 1:00:53
We have more health commissioners, including for genomics, and we both hope for a more meaningful discussion on weight loss therapies, the opportunities, access barriers, and their system-changing impact. Telehealth is here to stay, particularly in specific therapeutic areas, while one state has introduced political donations reform that could have a broader impact.
The Dispatched 'Week in Review' Podcast - 27 June 27.06.2025 48:41
The health department has released its incoming ministerial brief to the reappointed Mark Butler, revealing internal government discussions over the future funding of new PBS listings, and hinting at limiting the implementation of the HTA Review recommendations to a small number of technologies. It also contradicts the claim that new PBS listings take 466 days from TGA registration, suggesting tha...
The 'Dispatched' Podcast - Season 4, Episode 15 23.06.2025 47:30
In a country as wealthy as Australia, how is it fair or equitable that some can pay for new treatments, while most are forced to wait, while the government uses a laborious multi-year process to negotiate the best deal for itself? We are forced to live with a system that regularly treats human health like a failing business. Are we worth saving? We also live with a system whose underpinning framew...
The 'Dispatched' Podcast - 6 June 06.06.2025 44:52
Adding disability to health in an already full ministerial bandwidth and funding challenges. Trade policy and the PBS, and a presentation on the human consequences of our decision-making. Can a targeted diagnostic screening and the strangest patient case study? Times 0:00 - 9.45: Adding disability to health in an already full ministerial bandwidth and funding challenges 9.45 - 17:55: Trade policy,...
The 'Dispatched' Podcast - 16 May 2025 16.05.2025 1:00:00
A busy two weeks with an election and the addition of disability and the NDIS to the health portfolio. What does it mean? The credulous reflex response to comparisons between the US and Australian health systems. Why is denying access and out-of-pocket costs in Australia better than what happens in the US?
The Dispatched 'Week in Review' Podcast - 2 May 02.05.2025 39:37
What is the balance between building national sovereignty in health and protecting patient safety and community confidence in new technologies? Do we need to be careful? An election brings back memories of 'future' funds past.
The Dispatched Podcast 'Week/s in Review' - 24 April 23.04.2025 51:55
The health election debate mainly concerned bulk billing. New bureaucracies are rarely the solution to anything, and the challenge of faster funded access to new health technologies, particularly when advisory committees with power appear opposed. The complexity of weight-loss therapies presents opportunities.
The 'Dispatched' Podcast - 'Week in Review' 11 April 11.04.2025 49:39
Australia's election is two weeks in, and we're having trouble engaging. How positional power and 'expertism' can be confused and the value of a transparent and open forum.
The 'Dispatched' Podcast - 4 April 04.04.2025 51:46
The industry's 'Faustian bargain' on the 'sanctity' of the PBS, the challenge so many have in being clear about the problem, and why Pathology Australia provides an important lesson. Another wrong political message on newborns, why dentists might be worried, positive news on a critical medicines reform, and kudos to a pharmacy chain for promoting flu vaccines.
The 'Week in Review' Podcast - 28 March 28.03.2025 33:36
US criticism of the PBS is like catnip for some people, they can't resist it, even if it's the same criticism articulated by multiple Australian stakeholders and the health minister. The strange secrecy over the government's review of arrangements for blood supply products and the terrible treatment of a female academic leader.
The 'Week in Review' Podcast - 21 March 20.03.2025 30:18
A total victory for pharmacy with the prime minister's appearance at their showcase annual event. We discuss the confected outrage over US interest in the PBS, which is hardly new, and why the industry needs to lead this debate because its reputation and change agenda are being trashed. Much of what PhRMA is arguing reflects what Health Minister Mark Butler said on Sunday when he announced ne...
The 'Dispatched' week in review podcast - 7 March 07.03.2025 43:25
Medicines Australia will be appointing a new chair. To what extent does it matter? The participation model means that the industry might be effectively shackled to the 'change' table rather than having a seat at it. The government has worked it out, constantly increasing the price of participation and limiting exclusionary discussions about change. How does that need to change?
The 'Week in Review' Podcast - 2 March 02.03.2025 1:06:50
A review of Senate Estimates, with irritating warnings, too much passivity, and passive-aggressive responses (0.00-4.50). Revelations on how oral contraceptives navigated the funding process and the drivers of that outcome (4.51-14.10). We disagree on the role of advisory committees in policymaking (14.10-25.00). The impact of individuals in health policy, how change can have a significant effect,...
The 'Week in Review' Podcast - 21 February 21.02.2025 44:42
A serious discussion about reforming Australia's use of health technology assessment should start with patient rights and the imposition of new obligations on advisory committees and decision-makers. The signs of institutional capture and the dangers of concessions as the price for participation. Once again, pharmacy sets the standard for advocacy with its consistent argument that out-of-pock...
The 'Week in Review' Podcast - 14 February 14.02.2025 48:30
A major structural shift in the PBS with the government moving to break a long-held article of faith (00:10-9:30). Why can't we debate HTA using some plain language and straight talking (9:30-20:20)? Research grants about patients that patients can't apply for (20:20-28:30), pathology pushing for more funding (28:30-37:00), essential questions for our public health system (37:00-47:00),...
The 'Dispatched' Podcast - 7 February 06.02.2025 40:50
Genetics and genomics are the focus of this week's episode. It was a significant week with the release of one organisation's pre-budget submission and a new national framework. Not everyone is happy, but is the criticism fair?
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.